Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Braz. j. med. biol. res ; 47(4): 328-333, 8/4/2014. graf
Artigo em Inglês | LILACS | ID: lil-705768

RESUMO

In cardiac and skeletal muscle, eugenol (μM range) blocks excitation-contraction coupling. In skeletal muscle, however, larger doses of eugenol (mM range) induce calcium release from the sarcoplasmic reticulum. The effects of eugenol are therefore dependent on its concentration. In this study, we evaluated the effects of eugenol on the contractility of isolated, quiescent atrial trabeculae from male Wistar rats (250-300 g; n=131) and measured atrial ATP content. Eugenol (1, 3, 5, 7, and 10 mM) increased resting tension in a dose-dependent manner. Ryanodine [100 µM; a specific ryanodine receptor (RyR) blocker] and procaine (30 mM; a nonspecific RyR blocker) did not block the increased resting tension induced by eugenol regardless of whether extracellular calcium was present. The myosin-specific inhibitor 2,3-butanedione monoxime (BDM), however, reversed the increase in resting tension induced by eugenol. In Triton-skinned atrial trabeculae, in which all membranes were solubilized, eugenol did not change resting tension, maximum force produced, or the force vs pCa relationship (pCa=-log [Ca2+]). Given that eugenol reduced ATP concentration, the increase in resting tension observed in this study may have resulted from cooperative activation of cardiac thin filaments by strongly attached cross-bridges (rigor state).


Assuntos
Animais , Masculino , Cálcio/fisiologia , Eugenol/farmacologia , Acoplamento Excitação-Contração/efeitos dos fármacos , Átrios do Coração/efeitos dos fármacos , Força Muscular/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Trifosfato de Adenosina/análise , Anestésicos Locais/farmacologia , Eugenol/administração & dosagem , Técnicas In Vitro , Luciferases , Músculo Esquelético/efeitos dos fármacos , Procaína/farmacologia , Ratos Wistar , Rianodina/farmacologia
2.
Braz J Med Biol Res ; 47(4): 328-33, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24676474

RESUMO

In cardiac and skeletal muscle, eugenol (µM range) blocks excitation-contraction coupling. In skeletal muscle, however, larger doses of eugenol (mM range) induce calcium release from the sarcoplasmic reticulum. The effects of eugenol are therefore dependent on its concentration. In this study, we evaluated the effects of eugenol on the contractility of isolated, quiescent atrial trabeculae from male Wistar rats (250-300 g; n=131) and measured atrial ATP content. Eugenol (1, 3, 5, 7, and 10 mM) increased resting tension in a dose-dependent manner. Ryanodine [100 µM; a specific ryanodine receptor (RyR) blocker] and procaine (30 mM; a nonspecific RyR blocker) did not block the increased resting tension induced by eugenol regardless of whether extracellular calcium was present. The myosin-specific inhibitor 2,3-butanedione monoxime (BDM), however, reversed the increase in resting tension induced by eugenol. In Triton-skinned atrial trabeculae, in which all membranes were solubilized, eugenol did not change resting tension, maximum force produced, or the force vs pCa relationship (pCa=-log [Ca2+]). Given that eugenol reduced ATP concentration, the increase in resting tension observed in this study may have resulted from cooperative activation of cardiac thin filaments by strongly attached cross-bridges (rigor state).


Assuntos
Cálcio/fisiologia , Eugenol/farmacologia , Acoplamento Excitação-Contração/efeitos dos fármacos , Átrios do Coração/efeitos dos fármacos , Força Muscular/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Trifosfato de Adenosina/análise , Anestésicos Locais/farmacologia , Animais , Eugenol/administração & dosagem , Técnicas In Vitro , Luciferases , Masculino , Músculo Esquelético/efeitos dos fármacos , Procaína/farmacologia , Ratos Wistar , Rianodina/farmacologia
3.
Lipids ; 48(9): 889-97, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23743575

RESUMO

Episodes of acute exacerbation are the major clinical feature of asthma and therefore represent an important focus for developing novel therapies for this disease. There are many reports that the n-3 fatty acids found in fish oil exert anti-inflammatory effects, but there are few studies of the action of fish oil on airway smooth muscle (ASM) function. In the present investigation, we evaluated the effect of fish oil supplementation on smooth muscle force of contraction in ovalbumin-induced asthmatic Wistar rats, and its consequences on static lung compliance, mucus production, leukocyte chemotaxis and production of proinflammatory cytokines. Fish oil supplementation suppressed the infiltration of inflammatory cells into the lung in asthmatic animals (2.04 ± 0.19 × 10(6) cells vs. 3.33 ± 0.43 × 10(6) cells in the control asthmatic group; P < 0.05). Static lung compliance increased with fish oil supplementation in asthmatic rats (0.640 ± 0.053 mL/cm H2O vs. 0.399 ± 0.043 mL/cm H2O; P < 0.05). However, fish oil did not prevent asthma-associated lung eosinophilia and did not affect the concentrations of tumor necrosis factor-α and interleukin-1ß in lung tissue or the proportion of the airways obliterated with mucus. Fish oil had no effect on the force of contraction in asthmatic rats in response to acetylcholine (3.026 ± 0.274 mN vs. 2.813 ± 0.364 mN in the control asthmatic group). In conclusion, although fish oil exerts some benefits in this model of asthma, its effectiveness appears to be limited by an inefficient action on airway smooth muscle function.


Assuntos
Asma/fisiopatologia , Óleos de Peixe/farmacologia , Músculo Liso/efeitos dos fármacos , Traqueia/efeitos dos fármacos , Acetilcolina/farmacologia , Análise de Variância , Animais , Asma/induzido quimicamente , Líquido da Lavagem Broncoalveolar/citologia , Broncodilatadores/farmacologia , Suplementos Nutricionais , Eosinófilos/efeitos dos fármacos , Eosinófilos/patologia , Óleos de Peixe/administração & dosagem , Técnicas In Vitro , Interleucina-1beta/metabolismo , Isoproterenol/farmacologia , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Complacência Pulmonar/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Linfócitos/patologia , Macrófagos/efeitos dos fármacos , Macrófagos/patologia , Masculino , Músculo Liso/fisiopatologia , Neutrófilos/efeitos dos fármacos , Neutrófilos/patologia , Ovalbumina , Ratos , Ratos Wistar , Traqueia/fisiopatologia , Fator de Necrose Tumoral alfa/metabolismo , Vasodilatadores/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA